Concepts Inc (NASDAQ:TMCI) received an upgrade from BTIG, with analyst Ryan Zimmerman changing the stock rating from Neutral to Buy and setting a new price target of $16.00. This upgrade comes after a ...

The SpeedAkin™ implant broadens the procedural versatility of Treace’s flagship SpeedPlate™ fixation platform, which is advancing a new standard in bone fusion fixation. Akin osteotomies are ...

Concepts announced the successful completion of the first cases utilizing its SpeedAkin Anatomic Compression Implant, ...

as well as other common bone fusion procedures of the foot. For more information, please visit www.treace.com.

Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional ...

Treace Medical Concepts, Inc.’s TMCI share price has surged by 10.21%, which has investors questioning if this is right time ...

(RTTNews) - Treace Medical Concepts, Inc. (TMCI), a leading innovator in medical technologies for bunion and midfoot deformity treatment, announced on Tuesday the successful completion of its ...

Treace Medical Concepts, Inc. has announced the limited market release of its new Percuplasty™ Percutaneous 3D Bunion Correction® System, following successful initial surgical cases. This ...

“The SpeedAkin™ implant leverages our proprietary SpeedPlate™ technology in a differentiated Akin osteotomy solution, further expanding our best-in-class bunion focused portfolio.” said John T. Treace ...

2025 Outlook Treace plans to provide 2025 financial guidance during its fourth quarter 2024 earnings conference call, which is currently scheduled for Thursday, February 27, 2025, at 4:30 p.m ...